Business and Finance

Apr 28th, 2021

Announcement of Absorption-Type Merger (Simplified Merger/Short-Form Merger) of a Wholly Owned Subsidiary
Apr 15th, 2021

Ajinomoto Co., Inc. Concludes Agreement to Sell Its Equity Stake in a Feed-use Amino Acid Company in Europe
Apr 6th, 2021

The Ajinomoto Group Completes the Consolidation of the Domestic R&D Bases of Its Food Products Business – Accelerating the Technological Integration of Three Group Companies to Help Resolve Food and Health Issues
Mar 30th, 2021

Ajinomoto Co., Inc. to Establish a Dedicated Organization for Creating Businesses That Target Gen-Z – Co-Creation of Value with Startups and Universities
Mar 26th, 2021

Ajinomoto Co., Inc. and Bright Peak Therapeutics Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines
Feb 26th, 2021

Ajinomoto Co., Inc. Plans to Sell Its Entire Equity Stake in a Feed-use Amino Acid Company in Europe – Structural Reform of Animal Nutrition Business to be Completed to Accelerate Asset-Light Management
Jan 29th, 2021

Revision to Consolidated Performance Forecast of Ajinomoto Co., Inc. for Fiscal 2020
Dec 21st, 2020

Ajinomoto Co., Inc. Makes a Supplements Company in Ireland a Wholly Owned Subsidiary – Entering Europe’s Oral Nutritional Supplements Market
Dec 16th, 2020

Ajinomoto Co., Inc. Establishes a Corporate Venture Capital Arm – Driving Business Model Transformation for Value Creation in the Provision of Solutions for Food and Health Issues
Dec 15th, 2020

The Ajinomoto Group Enters into its First ESG Finance Agreement in Malaysia – AJINOMOTO (MALAYSIA) BERHAD Carries Out Capital Procurement Through “Sustainability-Linked Finance”